Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease

Autor: Philip D Adamson, Julie C. Yates, Jørgen Vestbo, Fernando J. Martinez, David E. Newby, Nicholas L. Mills, Nicholas J. Cowans, Julie A. Anderson, Bartolome R. Celli, Peter M.A. Calverley, Courtney Crim, Ian J. Dixon, Robert D. Brook

Publikováno v: Journal of the American College of Cardiology
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Adamson, P D, Anderson, J A, Brook, R D, Calverley, P M A, Celli, B R, Cowans, N J, Crim, C, Dixon, I J, Martinez, F J, Newby, D E, Vestbo, J, Yates, J C & Mills, N L 2018, ' Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease ', Journal of the American College of Cardiology, vol. 72, no. 10, pp. 1126-1137 . https://doi.org/10.1016/j.jacc.2018.06.051
Adamson, P D, Anderson, J A, Brook, R D, Calverley, P M A, Celli, B R, Cowans, N J, Crim, C, Dixon, I J, Martinez, F J, Newby, D E, Vestbo, J, Yates, J C & Mills, N L 2018, ' Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease ' vol. 72, no. 10, pp. 1126-1137 . DOI: 10.1016/j.jacc.2018.06.051

Background: Patients with chronic obstructive pulmonary disease (COPD) have increased risk of cardiovascular events.Objectives: This study evaluated the association between high-sensitivity cardiac troponin I concentration and cardiovascular events i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a45b7083fe62d2a7d7170897118ae5
http://europepmc.org/articles/PMC6119211

Serum Levels of Club-Cell Protein 16 (CC-16), Surfactant Protein D (SPD), soluble Receptor of Glycation End-products (sRAGE), Fibrinogen and C-Reactive Protein (CRP) and FEV1 Decline, Exacerbations and Mortality in SUMMIT

Autor: Robert H. Brook, Bartolome R. Celli, Andrea Morris, Victor Kim, Courtney Crim, Peter M.A. Calverley, Fernando J. Martinez, Ian J. Dixon, David E. Newby, Julie C. Yates, Jørgen Vestbo, Julie A. Anderson

Publikováno v: Clinical Problems COPD.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::15ddcf32f318201b665a062e3e702a67
https://doi.org/10.1183/1393003.congress-2017.oa511

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

Autor: Sofia, Tzimopoulou, Vincent J, Cunningham, Thomas E, Nichols, Graham, Searle, Nick P, Bird, Prafull, Mistry, Ian J, Dixon, William A, Hallett, Brandon, Whitcher, Andrew P, Brown, Marina, Zvartau-Hind, Narinder, Lotay, Robert Y K, Lai, Mary, Castiglia, Barbara, Jeter, Julian C, Matthews, Kewei, Chen, Dan, Bandy, Eric M, Reiman, Michael, Gold, Eugenii A, Rabiner, Paul M, Matthews

Publikováno v: Journal of Alzheimer's disease : JAD. 22(4)

Here we report the first multi-center clinical trial in Alzheimer's disease (AD) using fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) measures of brain glucose metabolism as the primary outcome. We contrasted effects of 12 months trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2da6fd6379fb687d2b1b213992a7637a
https://pubmed.ncbi.nlm.nih.gov/20930300